Am J Cardiol

1. PARTANI E, Shi C, Stram D, Palakodeti S, et al
   Pregnancy Outcomes in Women with Cardiovascular Disease: A Retrospective Cohort Study from Kaiser Permanente Northern California.
   Am J Cardiol. 2026 Jan 16:S0002-9149(26)00004.
   

   >> Share

   
   
2. SAMHAN A, McGee KA, Flaherty JD
   Severe Aortic Stenosis and Coronary Artery Disease - Trying to Pick a Winning Strategy.
   Am J Cardiol. 2026 Jan 16:S0002-9149(26)00002.
   

   >> Share

   
   

   
   Am J Emerg Med

3. ANDERSON J, Rushton WF, Burleson SL, Thompson M, et al
   Calcium channel antagonists and point-of-care ultrasound: A case series.
   Am J Emerg Med. 2026;100:138-141.
   

   >> Share

   
   
4. GAMBOA S, Shenvi C
   The great imitator: Hyperkalemia presenting with paralysis and ST segment elevations.
   Am J Emerg Med. 2026;100:59-61.
   

   >> Share

   
   

   
   Ann Intern Med

5. RAMASWAMY R
   In older adults with impaired physical performance after MI, multidomain rehabilitation reduced CV death or CV hospitalization at 1 y.
   Ann Intern Med. 2026;179:JC5.
   

   >> Share

   
   

   
   Ann Thorac Surg

6. DELL'AQUILA AM, Georgevici AI, Wisniewski K, Szabo G, et al
   Risk Profile and Outcomes of Patients Requiring Coronary Revascularization as Concomitant Procedure to Repair of Type A Aortic Dissection.
   Ann Thorac Surg. 2026;121:329-336.
   

   >> Share

   
   

   
   Arterioscler Thromb Vasc Biol

7. HAMANA T, Gaynor BJ, Grogan A, Turoni-Glitz A, et al
   Lipid-Related Polygenic Risk Score and Its Association With Plaque Rupture Versus Erosion.
   Arterioscler Thromb Vasc Biol. 2026;46:e323942.
   

   >> Share

   
   

   
   BMJ

8. 
   CORRECTION: Exposure to sugar rationing in first 1000 days after conception and long term cardiovascular outcomes: natural experiment study.
   BMJ. 2026;392:s119.
   

   >> Share

   
   

   
   Can J Cardiol

9. MALIK MI, Lou W, Bisleri G, Connelly K, et al
   Machine Learning Reveals How Depression Influences Chest Pain Localization and Its Predictive Value for Coronary Artery Disease.
   Can J Cardiol. 2025 Sep 17:S0828-282X(25)01169.
   

   >> Share

   
   

   
   Circ Cardiovasc Imaging

10. SANTOS-GALLEGO CG, Requena-Ibanez JA, Picatoste B, Fardman B, et al
    Correction to: "Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction".
    Circ Cardiovasc Imaging. 2026;19:e000090.
    

    >> Share

    
    

    
    Circ Cardiovasc Interv

11. MAEHARA A, Kirtane AJ, Genereux P, Matsumura M, et al
    Calcium Modification After Orbital Atherectomy and Balloon Angioplasty in Severely Calcified Lesions: The ECLIPSE OCT Substudy.
    Circ Cardiovasc Interv. 2026;19:e015588.
    

    >> Share

    
    
12. SHLOFMITZ E, Ali ZA, Maehara A, Mintz GS, et al
    Correction to "Intravascular Imaging-Guided Percutaneous Coronary Intervention: A Universal Approach for Optimization of Stent Implantation".
    Circ Cardiovasc Interv. 2026;19:e000099.
    

    >> Share

    
    

    
    Circ Heart Fail

13. ODUTAYO A, Bhatt DL, Sridhar VS, Szarek M, et al
    Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial.
    Circ Heart Fail. 2026 Jan 22:e013054. doi: 10.1161/CIRCHEARTFAILURE.125.013054.
    

    >> Share

    
    

    
    Circulation

14. MUNZEL T, Luscher T, Kramer CM, Churchwell K, et al
    Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federat
    Circulation. 2026 Jan 20. doi: 10.1161/CIRCULATIONAHA.125.079034.
    

    >> Share

    
    
15. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Correction to: Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2026;153:e19.
    

    >> Share

    
    
16. CHO Y, Kang D, Lim H, Lee H, et al
    Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study.
    Circulation. 2026 Jan 23. doi: 10.1161/CIRCULATIONAHA.125.078919.
    

    >> Share

    
    
17. SUN P
    Letter by Sun Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e16.
    

    >> Share

    
    
18. MAENG M, Thrane PG, Erlinge D, Maehara A, et al
    Response by Maeng et al to Letters Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e17-e18.
    

    >> Share

    
    
19. PYRPYRIS N, Dimitriadis K, Tsioufis K
    Letter by Pyrpyris et al Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e14-e15.
    

    >> Share

    
    
20. HE J, Zhu Y
    Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
    Circulation. 2026;153:185-188.
    

    >> Share

    
    

    
    Clin Cardiol

21. LAPPALAINEN L, Lavikainen P, Roine RP, Sintonen H, et al
    The Effect of Age on Improvement in Health-Related Quality of Life After Percutaneous Coronary Intervention.
    Clin Cardiol. 2026;49:e70260.
    

    >> Share

    
    

    
    Eur Heart J

22. REHMAN MB, Bjornson E, Adiels M, Morze J, et al
    Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart disease.
    Eur Heart J. 2026 Jan 22:ehaf1124. doi: 10.1093/eurheartj/ehaf1124.
    

    >> Share

    
    

    
    Hypertension

23. JENSEN ET, Ahmed AM
    Postpartum as a Window of Opportunity to Improve Women's Cardiovascular Health.
    Hypertension. 2026;83:e25924.
    

    >> Share

    
    

    
    Int J Cardiol

24. HAKIM D, Ahmed M, Koo C, Coskun AU, et al
    Role of endothelial shear stress metrics in the development and eruption of coronary calcified nodules.
    Int J Cardiol. 2026;447:134117.
    

    >> Share

    
    
25. DING X, Dang W, Li W, Wang M, et al
    Impact of G protein-coupled receptor autoantibodies on clinical outcomes in patients with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2026 Jan 18:134185. doi: 10.1016/j.ijcard.2026.134185.
    

    >> Share

    
    

    
    J Am Coll Cardiol

26. BOEDDINGHAUS J, Lopez-Ayala P, Thurston AJF, Lee KK, et al
    Cardiovascular Risk Across Myocardial Injury and Infarction Categories Using the Universal Definition: An Individual Patient-Level Data Meta-Analysis.
    J Am Coll Cardiol. 2025 Dec 10:S0735-1097(25)10348.
    

    >> Share

    
    
27. MUNZEL T, Luscher T, Kramer CM, Churchwell K, et al
    Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federat
    J Am Coll Cardiol. 2026 Jan 20:S0735-1097(26)00078.
    

    >> Share

    
    
28. DZIEWIERZ A, Bobrowska B, Zasada W, Siudak Z, et al
    From Pathophysiology to Etiology: A Call for Precise Diagnosis in Young Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2026 Jan 14:S0735-1097(25)10411.
    

    >> Share

    
    
29. MA T, Guo Z, Xue Y, Yuan H, et al
    Metabolic Dysfunction-Associated Steatotic Liver Disease and CKM Syndrome: The Role of the Liver in Cardiovascular Risk Stratification.
    J Am Coll Cardiol. 2026 Jan 14:S0735-1097(25)10412.
    

    >> Share

    
    
30. WADHERA RK, Waken RJ, Wang F, Figueroa JF, et al
    Hospitalizations and Mortality Among Medicare Beneficiaries at Cardiovascular Risk: Disruptions and Recovery From the COVID-19 Pandemic.
    J Am Coll Cardiol. 2026 Jan 9:S0735-1097(25)10338.
    

    >> Share

    
    
31. KRAMER CM, Blackwell J, Jones SO 4th, Kenigsberg D, et al
    Cardiovascular ASCs: Transforming Cardiovascular Procedural Care Through High Value Ambulatory Models.
    J Am Coll Cardiol. 2026 Jan 21:S0735-1097(25)10566.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

32. KIANFAR T, Fallah M, Ramezani F, Rakhshan K, et al
    Dapagliflozin reduces myocardial injuries through modulation of H3K27me3 and SIRT1 in the male rat model of myocardial ischemia reperfusion.
    J Cardiovasc Pharmacol. 2026 Jan 22. doi: 10.1097/FJC.0000000000001795.
    

    >> Share

    
    
33. KUMAR S, Thotakura S, Kearney KE, Lombardi WL, et al
    Protamine for Coronary Perforation in Chronic Total Occlusion Percutaneous Coronary Intervention.
    J Cardiovasc Pharmacol. 2026 Jan 22. doi: 10.1097/FJC.0000000000001791.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

34. 
    Correction to: "Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome".
    J Clin Endocrinol Metab. 2026;111:e646.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

35. ANDERSON M, Zeeshan A, Katlaps GJ, Funamoto M, et al
    Clinical Outcomes in Acute Myocardial Infarction Cardiogenic Shock Patients Supported With The Impella 5.5, High-Flow, Surgically Implanted Micro-Axial Flow Pump.
    J Thorac Cardiovasc Surg. 2026 Jan 16:S0022-5223(26)00019.
    

    >> Share

    
    

    
    JAMA

36. BERGSTROM G, Engstrom G, Bjornson E, Adiels M, et al
    Coronary Computed Tomography Angiography in Prediction of First Coronary Events.
    JAMA. 2026;335:245-254.
    

    >> Share

    
    
37. RUBIN R
    Stress May Link Depression and Anxiety to Cardiovascular Disease.
    JAMA. 2026 Jan 23. doi: 10.1001/jama.2025.25865.
    

    >> Share

    
    

    
    Lancet

38. NAUCK MA, Tuttle KR, Tschop MH, Bluher M, et al
    Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits.
    Lancet. 2026 Jan 14:S0140-6736(25)02105-1. doi: 10.1016/S0140-6736(25)02105.
    

    >> Share

    
    

    
    Mayo Clin Proc

39. COLLINGS PJ, Wang M, Chen Z, Shi Q, et al
    Cardiorespiratory Fitness, Genetic Risk, and Incident Atherosclerotic Cardiovascular Events: A Prospective Cohort Study.
    Mayo Clin Proc. 2026 Jan 21:S0025-6196(25)00477.
    

    >> Share

    
    
40. XIA X, Chen S, Tian X, Xu Q, et al
    Hypothetical Interventions on Multiple Cardiometabolic Risk Factors for Cardiovascular Disease Prevention: A Target Trial Emulation.
    Mayo Clin Proc. 2026 Jan 23:S0025-6196(25)00611.
    

    >> Share

    
    

    
    Mol Cell Biochem

41. IQBAL A, Ghani MW, Shao N, Zhang Y, et al
    Advances in MicroRNA-Based Therapies for Cardiac Repair: Emerging Strategies for Treating Myocardial Infarction.
    Mol Cell Biochem. 2026 Jan 20. doi: 10.1007/s11010-025-05476.
    

    >> Share

    
    

    
    PLoS One

42. LIN X, Cheng Z, Ji W, Mei Z, et al
    Prognostic significance of residual functional SYNTAX score II in acute myocardial infarction.
    PLoS One. 2026;21:e0340784.
    

    >> Share

    
    

    
    Prog Cardiovasc Dis

43. BIELINSKI SJ, St Sauver JL, Borlaug BA
    Visceral adiposity tissue: A promising biomarker to improve cardiovascular disease risk assessment.
    Prog Cardiovasc Dis. 2026 Jan 17:S0033-0620(26)00003.
    

    >> Share

    
    
44. SHEIKH S, Khoja A, Naeem U, Fayyaz M, et al
    Longitudinal study of cardiovascular-kidney-metabolic syndrome risk assessment among adolescents and young adults (10-45 years) in Pakistan (LIFECARD): Study design and methodology.
    Prog Cardiovasc Dis. 2026 Jan 20:S0033-0620(26)00005.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share